首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design and synthesis of 2-phenylnaphthalenoids as inhibitors of DNA topoisomerasella and antitumor agents
【24h】

Design and synthesis of 2-phenylnaphthalenoids as inhibitors of DNA topoisomerasella and antitumor agents

机译:设计和合成2-苯基萘类化合物作为DNA拓扑异构体抑制剂和抗肿瘤剂

获取原文
获取原文并翻译 | 示例
       

摘要

Forty eight 2-phenylnaphthalenoids were designed and successfully synthesized. Their in vitro cyto-toxicities against the proliferations of MDA-MB-231, A549 and HeLa cell lines and inhibitory activities on DNA topoisomerase were evaluated. The quantitative structure-activity relationship (QSAR) studies were established on the basis of cytotoxicity data from MDA-MB-231 cell line. Among these compounds, compound 5 showed potent antiproliferative activity (IC_(50) = 1 muM) against MDA-MB-231 cells and inhibitory activity on topoisomerasella. Further, in vivo antitumor study with xenograft nude mice indicated that compound 5 inhibited the growth of MDA-MB-231 cells and showed lower toxicity than etoposide (VP16). This work indicates that 2-phenylnaphthalenoids represent a novel type of TopoIIa-inhibitory scaffold for developing new antitumor chemotherapeutic agents.
机译:设计并成功合成了四十八个2-苯基萘。评估了它们对MDA-MB-231,A549和HeLa细胞增殖的体外细胞毒性以及对DNA拓扑异构酶的抑制活性。基于来自MDA-MB-231细胞系的细胞毒性数据建立了定量构效关系(QSAR)研究。在这些化合物中,化合物5对MDA-MB-231细胞显示出强效的抗增殖活性(IC_(50)= 1μM),并对拓扑异构体具有抑制活性。此外,对异种移植裸鼠的体内抗肿瘤研究表明,化合物5抑制MDA-MB-231细胞的生长,并显示出比依托泊苷(VP16)更低的毒性。这项工作表明2-苯基萘类化合物代表一种新型的TopoIIa抑制支架,用于开发新的抗肿瘤化学治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号